Anti-SARS-CoV-2 S1 (RBM) Neutralizing Antibody (V3S-0723-XY1) (CAT#: V3S-0723-XY1)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description The antibody 10-5B is a neutralizing IgG against SARS-CoV-2 Spike S1 protein. The epitope of this antibody belongs to the RBD-2 community (Class 1) and has extensive overlap with the ACE2-binding site on the RBM. The 10-5B antibody is capable of neutralizing live SARS-CoV-2 wild type, Beta, Delta, Omicron BA.1 and Omicron BA.2 variants.
Clonality Monoclonal
Host Species Human
Target Species SARS-CoV-2 (WT, Beta, Delta, Omicron BA.1, BA.2, BA.2.12.1, BA.3 and XD subvariant)
Epitope 10-5B binds to the residues Y449, L455, F456, N477, V483, A484, G485, F486, N487, C488, Y489, and R493 on the receptor-binding motif (RBM).

Property

Expression Species HEK293F or CHO cell line
Conjugation Unconjugated
Purity >95%
Endotoxin <1 EU/mg
Form Liquid
Purification Protein A purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics.

Applications

Application ELISA; BLI; Neut
Application Notes This antibody's neutralizing capacity was tested by Neutralization assay and the results demonstrated that IC50 value of 10-5B is below 150 ng/mL.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target SARS-CoV-2 S1
Alternative Name Severe acute respiratory syndrome coronavirus 2 Spike S1
Research Area Coronavirus Disease 2019
Related Disease Coronavirus Disease 2019
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry